losartan has been researched along with Menopause in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Taha, M | 1 |
| Rius, C | 1 |
| Hermenegildo, C | 1 |
| Noguera, I | 1 |
| Cerda-Nicolas, JM | 1 |
| Issekutz, AC | 1 |
| Jose, PJ | 1 |
| Cortijo, J | 1 |
| Morcillo, EJ | 1 |
| Sanz, MJ | 1 |
1 other study available for losartan and Menopause
| Article | Year |
|---|---|
Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Animals; Benzazepines; Case-Control Studies; Cell Ad | 2009 |